TY - CHAP
T1 - CHAPTER 5
T2 - Big Data and Its Emerging Role in Precision Medicine and Therapeutic Response
AU - Epsi, Nusrat J.
AU - Panja, Sukanya
AU - Mitrofanova, Antonina
N1 - Publisher Copyright:
© The Royal Society of Chemistry 2021.
PY - 2021
Y1 - 2021
N2 - High-throughput molecular profiling has revolutionized our understanding of molecular mechanisms involved in disease progression and treatment response. As more information from patients' high-throughput molecular and clinical profiles (i.e., Big Data) becomes accessible, there is a significant shift in personalized and precision-based patient-centric approaches, allowing for an individualized therapeutic planning and more accurate prediction of therapeutic success or failure. Here, we discuss the most commonly utilized Big Data types (touching on most recent advances), including genome, DNA methylome, and transcriptome (i.e., RNA abundance and alternative splicing), alongside computational methods for their effective analysis. Further, we discuss how Big Data integration helps in unveiling complex molecular relationships involved in treatment response in oncology, including identification of biological pathways as markers of treatment resistance, and how its utilization builds a foundation for improved clinical decision making and precision medicine.
AB - High-throughput molecular profiling has revolutionized our understanding of molecular mechanisms involved in disease progression and treatment response. As more information from patients' high-throughput molecular and clinical profiles (i.e., Big Data) becomes accessible, there is a significant shift in personalized and precision-based patient-centric approaches, allowing for an individualized therapeutic planning and more accurate prediction of therapeutic success or failure. Here, we discuss the most commonly utilized Big Data types (touching on most recent advances), including genome, DNA methylome, and transcriptome (i.e., RNA abundance and alternative splicing), alongside computational methods for their effective analysis. Further, we discuss how Big Data integration helps in unveiling complex molecular relationships involved in treatment response in oncology, including identification of biological pathways as markers of treatment resistance, and how its utilization builds a foundation for improved clinical decision making and precision medicine.
UR - http://www.scopus.com/inward/record.url?scp=85098625098&partnerID=8YFLogxK
U2 - 10.1039/9781788019958-00088
DO - 10.1039/9781788019958-00088
M3 - Chapter
AN - SCOPUS:85098625098
T3 - RSC Detection Science
SP - 88
EP - 116
BT - Detection Methods in Precision Medicine
A2 - Yang, Mengsu
A2 - Thompson, Michael
PB - Royal Society of Chemistry
ER -